Safety and Efficacy of ACU-D1 in the Treatment of Acne Rosacea

Acne Rosacea Clinical Trial

Official title:
A RANDOMIZED, DOUBLE-BLIND, VEHICLE CONTROLLED, PROOF-OF CONCEPT STUDY OF THE SAFETY AND EFFICACY OF ACU-D1 OINTMENT IN SUBJECTS WITH ACNE ROSACEA

Status Completed

Clinical Trial Summary

The study evaluated the safety, tolerability, and efficacy of ACCU-D1 when applied twice daily for 12 weeks in adult participants with moderate to severe acne rosacea. Two-third of the participants received ACCU-D1 while one-third of the participants received vehicle control.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03064438
Study type	Interventional
Source	Accuitis, Inc.
Contact
Status	Completed
Phase	Phase 2
Start date	November 28, 2017
Completion date	June 18, 2018

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05108025` - DMT310-005 Topical in the Treatment of Acne Rosacea	Phase 2
Completed	`NCT02270411` - Inflammatory Cells From Various Pathologies
Completed	`NCT02147691` - Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study	Phase 4
Recruiting	`NCT04214483` - A Pilot Study to Explore the Role of Gut Flora in Acne
Completed	`NCT00041977` - Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne Rosacea	Phase 3
Completed	`NCT03003104` - DMT210 Topical Gel in the Treatment of Acne Rosacea	Phase 2
Completed	`NCT00580723` - Effects of PRK 124 Lotion in Acne Rosacea	Phase 1/Phase 2
Completed	`NCT04555525` - A Pilot Study on the Use of Seysara for Rosacea	Phase 4